The mission of the Drug Evaluation Alliance of Nova Scotia (DEANS) is to contribute to the health of Nova Scotians by encouraging appropriate drug use. To accomplish this, DEANS will:
The following pages carry information about the Drug Evaluation Alliance of Nova Scotia
Given the vast number of critical drug care issues which could potentially be identified, the DEANS Management Committee relies on the following criteria as a guide to prioritizing issues:
Recognizing its ultimate goal is to influence local behaviour, DEANS will, whenever possible, preferentially establish contracts with Nova Scotian-based suppliers of resources.
Although the Nova Scotia Department of Health is the primary funder for DEANS, external funding may be sought for special projects. The quality and character of the relationship between DEANS and its funders must be collaborative, but must not compromise the process of impartial research. Cognizant of the potential hazards of funding relationships, the Management Committee is responsible for ensuring the research and information agenda of DEANS is needs driven, based on relevance to encouraging appropriate drug use in Nova Scotia.
As a result, all contracted resources are required to establish policies and guidelines which govern their relationship with external funders and reflect the philosophy of DEANS. The DEANS Management Committee assumes the important task of managing potential conflicts.
In the development phase, DEANS was overseen by a Steering Committee with representatives from the Department of Health, Continuing Medical Education at Dalhousie University, the College of Pharmacy at Dalhousie University and the Drug Information Centre at the QEII Health Sciences Centre. When the development phase was completed, the Steering Committee was replaced by a Management Committee which is accountable to the Minister of Health for DEANS.
The Management Committee consists of individuals and/or designates with expertise to provide implementation and evaluation resources in the area of:
Depending on resource needs, other members may be added at any time.
Members of the Management Committee are appointed by the Department of Health on the recommendation of the contracted implementation/evaluation resources. The Manager of Drug Technology Assessment and other representatives from Pharmaceutical Services hold ex-officio status. Committee members are required to sign a Department of Health statement of confidentiality.
The Manager of Drug Technology Assessment functions as the Committee's secretariat. The Management Committee selects its own Chair. The Chair generally serves for two years.
Meetings are called at the discretion of the Chair, generally every second month. Agenda and background materials are sent to Committee members in advance of the meeting.
Committee members must declare any real or perceived conflict of interest. In situations where a real or perceived conflict of interest arises in the course of the Committee's work, members must declare its existence and other members of the Committee will take such conflict into consideration during the decision-making process. Depending on the nature of the conflict, the member may be asked to disqualify him/herself from participation in discussion or, depending on the situation, from membership on the Committee.
The Management Committee:
The Management Committee provides an annual report to the Minister of Health and stakeholders. The Chair of the Management Committee maintains regular, informal rapport with the Department of Health.
Academic detailing is a process by which a health educator visits a physician in his/her office to provide a 15 to 20 minute educational intervention on a specific topic. Academic detailing provides complete and objective information based on best available evidence. Physicians can receive continuing education credits for the time they spend with the health educator.
In the fall of 2001, a province-wide academic detailing service (ADS) was introduced in Nova Scotia. Funded by the Department of Health, the service is designed and operated by Dalhousie University Continuing Medical Education. The ADS is linked to the Department's drug program management structure through the Drug Evaluation Alliance of Nova Scotia (DEANS). DEANS provides direction on the topics addressed, monitors the execution and evaluation of each ADS topic and encourages and oversees complementary interventions. At present, the Service employs three part-time health educators: two pharmacists and one nurse.
The ADS is available to all physicians in Nova Scotia, but participation is completely voluntary.
For information about the ADS, refer to the Dalhousie University Continuing Medical Education website: http://cme.medicine.dal.ca.
Crown copyright 2011, Province of Nova Scotia, all rights reserved.
Page last updated 2013-05-15.